Goldstein Stanley I, Fan Alice C, Wang Zihao, Naineni Sai K, Cencic Regina, Garcia-Gutierrez Steve B, Patel Kesha, Huang Sidong, Brown Lauren E, Emili Andrew, Porco John A
BU Target Discovery & Proteomics Laboratory (BU-TDPL), Boston University, Boston, MA, USA.
Department of Chemistry, Boston University, Boston, MA, USA.
bioRxiv. 2024 Dec 21:2024.04.19.590252. doi: 10.1101/2024.04.19.590252.
Uncompetitive inhibition is an effective strategy for suppressing dysregulated enzymes and their substrates, but discovery of suitable ligands depends on often-unavailable structural knowledge and serendipity. Hence, despite surging interest in mass spectrometry-based target identification, proteomic studies of substrate-dependent target engagement remain sparse. Herein, we describe a strategy for the discovery of substrate-dependent ligand binding. Using proteome integral solubility alteration (PISA) assays, we show that simple biochemical additives can enable detection of RNA-protein-small molecule complexes in native cell lysates. We apply our approach to rocaglates, molecules that specifically clamp RNA to eukaryotic translation initiation factor 4A (eIF4A), DEAD-box helicase 3X (DDX3X), and potentially other members of the DEAD-box (DDX) helicase family. To identify unexpected interactions, we used a target class-specific thermal window and compared ATP analog and RNA base dependencies for key rocaglate-DDX interactions. We report and validate novel DDX targets of high-profile rocaglates - including the clinical candidate Zotatifin - using limited proteolysis-mass spectrometry and fluorescence polarization (FP) experiments. We also provide structural insight into divergent DDX3X affinities between synthetic rocaglates. Taken together, our study provides a model for screening uncompetitive inhibitors using a chemical proteomics approach and uncovers actionable DDX clamping targets, clearing a path towards characterization of novel molecular clamps and associated RNA helicases.
非竞争性抑制是抑制失调酶及其底物的有效策略,但合适配体的发现往往依赖于难以获得的结构知识和偶然性。因此,尽管基于质谱的靶点鉴定受到广泛关注,但关于底物依赖性靶点结合的蛋白质组学研究仍然很少。在此,我们描述了一种发现底物依赖性配体结合的策略。使用蛋白质组整体溶解度改变(PISA)分析,我们表明简单的生化添加剂能够在天然细胞裂解物中检测RNA-蛋白质-小分子复合物。我们将我们的方法应用于rocaglates,这类分子能特异性地将RNA与真核翻译起始因子4A(eIF4A)、DEAD盒解旋酶3X(DDX3X)以及DEAD盒(DDX)解旋酶家族的其他潜在成员结合。为了识别意外的相互作用,我们使用了靶点类别特异性的热窗口,并比较了关键rocaglate-DDX相互作用对ATP类似物和RNA碱基的依赖性。我们使用有限蛋白酶解-质谱和荧光偏振(FP)实验报告并验证了知名rocaglates的新型DDX靶点——包括临床候选药物Zotatifin。我们还提供了关于合成rocaglates之间不同DDX3X亲和力的结构见解。综上所述,我们的研究提供了一个使用化学蛋白质组学方法筛选非竞争性抑制剂的模型,并揭示了可操作的DDX结合靶点,为新型分子钳和相关RNA解旋酶的表征开辟了道路。